P2Y12 inhibitor pre-treatment in NSTE-ACS: translating trial evidence into UK clinical practice.
Kerrick Hesse, Jessica Stephens, Jonathan Adam Batty, Christopher David Bayliss et autres
BACKGROUND: Dual antiplatelet therapy is indicated in the management of non-ST-elevation acute coronary syndrome (NSTE-ACS) and can be administered before coronary angiography (pre-treatment) or after coronary anatomy is known. Based on clinical trials with rapid access to inpatient coronary angiography, clinical guidelines …
gb (code pays fourni par la source)
0 citations
White Rose Research Online (University of Leeds, The University of Sheffield, University of York)